Infectious Disease Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Miconazole 1% Ophthalmic Solution, Veterinary
Allen Loyd V Jr
|
May/Jun 2024
Pg. 245
|
Magic Mouthwashes- A Literature Review and Discussion of Common Compositions
McElhiney Linda F
|
Mar/Apr 2024
Pg. 94-98
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 58
|
Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications
Dharmian Jose Prakash, Sathiyaseelan Iraniammal, Renganathan Akshaya, Mubees Alamaan Mohamed, Naser Mohammed Yasin Abdul, Ramkrishnan Prakash, Arumugam Somasundaram
|
Nov/Dec 2023
Pg. 494-502
|
Environmental Sterility-control Practices in Selected Retail Pharmacies in Sri Lanka: A Study in Kandy District
Tennakoon TMIUK, Thayananthan Anoya
|
Nov/Dec 2023
Pg. 503-511
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment
Riepl Mike, Kaiser Joe
|
Sep/Oct 2023
Pg. 368-380
|
Crotamiton 10% Cream
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 412
|
Fluconazole 1% Thermoresponsive Gel
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 414-415
|
Idoxuridine 5% in Dimethyl Sulfoxide
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 417
|
Nitazoxanide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 420
|
Povidone Iodine Lotion
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 421
|
Silver Sulfadiazine 1% and Hydrocortisone 2% Gel
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 422-423
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID
Riepl Mike, Kaiser Joe
|
Jul/Aug 2023
Pg. 284-293
|
Chlorhexidine and Cetrimide Lotion
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 316
|
Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 319
|
Levofloxacin 0.5% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 324-325
|
Nystatin Oromucosal Gel
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 327
|
Rifampin 10-mg/mL Nasal Drops
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 328
|
Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt
Pramar Yahoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Jul/Aug 2023
Pg. 330-339
|
Warts: Pathophysiology, Types, Treatments, and Pharmaceutical Compounds
Touprong Robin, Thompson Tara, Williams LaVonn A
|
May/Jun 2023
Pg. 182-190
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development
Riepl Mike, Kaiser Joe
|
May/Jun 2023
Pg. 192-200
|
Acetaminophen 500-mg/mL Rectal Solution
Allen Loyd V Jr
|
May/Jun 2023
Pg. 232-233
|
Doxycycline 166.7-mg/mL Oral Suspension (Veterinary)
Allen Loyd V Jr
|
May/Jun 2023
Pg. 234
|
Gentamicin 480-mg/1000-mL Bladder Irrigation
Allen Loyd V Jr
|
May/Jun 2023
Pg. 235
|
Nystatin Oromucosal Viscous Suspension
Allen Loyd V Jr
|
May/Jun 2023
Pg. 239
|
PreScription: Amoxicillin Shortage Continues: Compounding Pharmacies Filling the Gap!
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 92
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment
Riepl Mike
|
Mar/Apr 2023
Pg. 98-107
|
Amphotericin B 0.1% Topical Microemulsion
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 143
|
Cyclosporine Topical Microemulsion
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 146
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants
Riepl Mike
|
Jan/Feb 2023
Pg. 12-21
|
Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 52
|
Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 56
|
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
|
Nov/Dec 2022
Pg. 480-488
|
Enrofloxacin 11.35 mg/mL in Ora-Blend, Veterinary
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 511
|
Flucytosine 50 mg/mL in Oral-Sweet and Ora-Plus
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 512
|
Miller's Modified Mouthwash
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 514
|
Amphotericin B 3% Otic Gel
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 422
|
Chlorhexidine Diacetate 2% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 424
|
Clindamycin Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 425
|
Clotrimazole 10-mg Troches
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 426
|
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 430
|
Effectiveness of a New Ultraviolet C Disinfection System to Inactivate Airborne Coronavirus in Different Environmental Conditions
Marianni Bruna, Polonini Hudson
|
Sep/Oct 2022
Pg. 432-435
|
Nystatin 250,000-unit Frozen Popsicles
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 327
|
Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 328
|
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Bartoll Aaron Puplà, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
|
Jul/Aug 2022
Pg. 330-335
|
Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops
Sahyoun Jean-Yves, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
|
Jul/Aug 2022
Pg. 336-341
|
Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Jul/Aug 2022
Pg. 342-351
|
A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide
Riepl Mike
|
May/Jun 2022
Pg. 189-193
|
Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion
Allen Loyd V Jr
|
May/Jun 2022
Pg. 238
|
Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
|
May/Jun 2022
Pg. 241
|
Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 142
|
Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 508
|
Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution
Zaid Abdel-Naser, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
|
Nov/Dec 2021
Pg. 523-527
|
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 415
|
Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 419
|
PreScription: Endemics, Epidemics, and Pandemics
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 268
|
Calculations
Stockton Shelly J
|
Jul/Aug 2021
Pg. 318
|
Calculations
Stockton Shelly J
|
May/Jun 2021
Pg. 230-231
|
Levofloxacin 50-mg/mL in Ora-Plus and Strawberry Syrup Suspension
Allen Loyd V Jr
|
May/Jun 2021
Pg. 232
|
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing
Riepl Mike
|
Mar/Apr 2021
Pg. 100-103
|
Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic
Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
|
Mar/Apr 2021
Pg. 109-113
|
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
|
Mar/Apr 2021
Pg. 169-175
|
Calculations
Stockton Shelly J
|
Jan/Feb 2021
Pg. 40
|
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
|
Jan/Feb 2021
Pg. 52-61
|
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
|
Jan/Feb 2021
Pg. 73-81
|
Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients
Nogales Luis Marcos, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol
|
Sep/Oct 2020
Pg. 358-364
|
Houston, We Have a Study': History-making African Research Relies on a Maverick Texas Pharmaceutical Compounder
Lovell Nancy
|
Sep/Oct 2020
Pg. 380-385
|
Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 407
|
Biotin Regulates Colonization and Growth of Candida albicans in the Catheter Lumen During Nutrient Infusions
Ohara Hiroshi, Matsuzaki Tetsuya, Ochiai Tatsuya, Hayasaka Masataka
|
Sep/Oct 2020
Pg. 420-425
|
PreScription: COVID-19 and Compounding Pharmacists
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 268
|
Compounding Pearls -- Wound Care: Burn Healing, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 282-285
|
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
McElhiney Linda F
|
Jul/Aug 2020
Pg. 287-295
|
Calculations
Stockton Shelly J
|
Jul/Aug 2020
Pg. 310
|
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 316
|
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
|
Jul/Aug 2020
Pg. 327-336
|
Tetracycline Hydrochloride 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 231
|
Comparative Stability Study of Unit-dose Vancomycin Hydrochloride Oral Solutions in Plastic Capped Oral Syringes and Plastic Sealed Dosage Cups
Brown Stacy, Lewis Paul
|
May/Jun 2020
Pg. 234-237
|
Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 133
|
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 134
|
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 136
|
Terbinafine 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 137
|
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 57
|
Isoniazid 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 58
|
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets
Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James
|
Jan/Feb 2020
Pg. 77-82
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
|
Sep/Oct 2019
Pg. 366-375
|
Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5%
Berisa Prado Silvia, Riestra Ayora Ana Cristina, Trelles Campa Adrián
|
Sep/Oct 2019
Pg. 418-421
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2
Zur Eyal
|
Jul/Aug 2019
Pg. 288-293
|
Rifampin 25 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 319
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1
Zur Eyal
|
May/Jun 2019
Pg. 200-207
|
Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2019
Pg. 231
|
Piperacillin 10 mg/mL in 0.9% Sodium Chloride Bladder Irrigation
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 60
|
Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome
Riepl Mike
|
Nov/Dec 2018
Pg. 456-465
|
Calculations
Stockton Shelly J
|
Jul/Aug 2018
Pg. 314
|
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 320
|
Oseltamivir Phosphate 15 mg/mL in SyrSpend SF
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 323
|
Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications
Agbi Kelechi E, Hover Sara, Carvalho Maria
|
May/Jun 2018
Pg. 196-202
|
Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 236
|
Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 239
|
Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats
Nani Marcel, Leone Andréia, Bom Vinícius Pedro, Buszinski Andrei Felipe, Oliveira de Souza Rebeca, Pinheiro Vanessa Alves, Danapoulos Panagiota, Swikidisa Rosita, Marquele-Oliveira Franciane, Cipriani Frade Marco Andrey, Berretta Andresa Aparecida, Nogueira Rodrigo José Lupatini
|
Mar/Apr 2018
Pg. 154-163
|
Metronidazole 50 mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 52
|
Miconazole 10% in Recura Topical Cream
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 53
|
Voriconazole 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 59
|
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 491
|
Fluconazole 10% in RECURA Cream
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 492
|
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 494
|
Vancomycin 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 499
|
Validation of the Technological Process of the Preparation "Milk by Vidal"
Savchenko LP, Mishchenko VA, Georgiyants VA
|
Nov/Dec 2017
Pg. 513-517
|
Vancomycin 50 mg/mL in Oral Syrup Suspension
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 417
|
Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt
Graves Richard A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
|
Sep/Oct 2017
Pg. 430-435
|
Betamethasone 0.1% and Neomycin 0.6% Gel-Cream
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 312
|
Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 313
|
Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori
Mah Xian-Jun, Gupta Vikas, Loch Srey Neth, Ahlenstiel Golo, van de Poorten David
|
Jul/Aug 2017
Pg. 330-333
|
Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding
Ligugnana Roberto
|
May/Jun 2017
Pg. 182-190
|
Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Mixon William, Roth Abby
|
May/Jun 2017
Pg. 193-203
|
Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
May/Jun 2017
Pg. 233
|
Ofloxacin 0.3% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2017
Pg. 236
|
PVP Iodine 10% Antiseptic Cream
Allen Loyd V Jr
|
May/Jun 2017
Pg. 237
|
Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2017
Pg. 239
|
Ketoconazole 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 149
|
Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date
Gautam Pradeep, Light Bob, Purvis Troy
|
Mar/Apr 2017
Pg. 154-159
|
Clindamycin 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 60
|
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
|
Nov/Dec 2016
Pg. 461-467
|
Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 507
|
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature
Larson Bayli, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H
|
Nov/Dec 2016
Pg. 521-525
|
Long-term Stability of Vancomycin Hydrochloride in Glucose 5% Polyolefin Bags: The Brand Name Versus a Generic Product
Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Sep/Oct 2016
Pg. 416-420
|
Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt
Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K
|
Sep/Oct 2016
Pg. 421-425
|
Gatifloxacin 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 319
|
Mebendazole 100-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 320
|
Neomycin Sulfate 25-mg/mL Oral Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 321
|
Nystatin 100,000-units Vaginal Inserts
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 322
|
Plasmingen and Hyaluronate Sodium Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 325
|
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations
Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
|
Jul/Aug 2016
Pg. 333-337
|
Stability of Ampicillin in Normal Saline and Buffered Normal Saline
Maher Moureddine, Jensen Kara J, Lee David, Nix David E
|
Jul/Aug 2016
Pg. 338-342
|
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Jul/Aug 2016
Pg. 347-350
|
Cefotetan Disodium Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 227
|
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
|
May/Jun 2016
Pg. 228
|
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration
Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C
|
May/Jun 2016
Pg. 236-238
|
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups
Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy
|
Mar/Apr 2016
Pg. 159-163
|
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 51
|
Mupirocin Calcium 2% Cream
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 52
|
Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 56
|
Voriconazole 10-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 57
|
Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care
Guimarães Anna Luísa Aguiar, Cunha Elisa Alves, Matias Fernanda Oliveira, Garcia Patrícia Guedes, Danopoulos Panagiota, Swikidisa Rosita, Pinheiro Vanessa Alves, Nogueira Rodrigo José Lupatini
|
Jan/Feb 2016
Pg. 58-62
|
Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation
Hergert Lisandro Y, Ravetti Soledad, Mazzieri Maria R
|
Jan/Feb 2016
Pg. 63-70
|
A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis
Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B
|
Jan/Feb 2016
Pg. 71-80
|
Cefepime Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 505
|
Cefotaxime 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 506
|
Mupirocin 2% Nasal Ointment
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 512
|
Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 406
|
Ofloxacin 0.3% Otic Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 408
|
Povidone Iodine 10% Cold Sore Paint
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 409
|
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 410
|
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra
|
Sep/Oct 2015
Pg. 432-436
|
Chloroquine Phosphate 250-mg Capsules
Allen Loyd V
|
Jul/Aug 2015
Pg. 327
|
Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 329
|
Phenazopyridine Hydrochloride 200-mg Capsules
Allen Loyd V Jr
|
May/Jun 2015
Pg. 245
|
Stability of Metronidazole Suspensions
Donnelly Ronald F, Ying James
|
May/Jun 2015
Pg. 248-251
|
Erythromycin 50-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 64
|
Hydroxychloroquine Sulfate 200-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 66
|
Mupirocin 2% Ointment
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 68
|
Clarithromycin 250-mg or 500-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 494
|
Oxacillin Sodium 167-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 502
|
Azithromycin 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 408
|
Bacitracin Topical Ointment
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 409
|
Sulfamethoxazole and Trimethoprim Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 415
|
Chloramphenicol 100-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 325
|
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding
Vu Nicole, Nguyen Devin, Kupiec Thomas C
|
Mar/Apr 2014
Pg. 123-130
|
Polymixin B Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 146
|
Aztreonam Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 60
|
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2
Horace Alexis E, Akbarian-Tefagh Jessica
|
Nov/Dec 2013
Pg. 446-450
|
Cefazolin 250-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 499
|
Ciprofloxacin 250-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 500
|
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
McPherson Timothy B, Neumann William L, Kolling William M
|
Nov/Dec 2013
Pg. 508-511
|
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
|
Sep/Oct 2013
Pg. 380-383
|
Acyclovir 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 414
|
Clindamycin 150-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 416
|
Acyclovir 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 326
|
Acyclovir 200-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 327
|
Amikacin Sulfate 250-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 329
|
Rifampin 300-mg and Isoniazid 150-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 334
|
Ethambutol 400-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 231
|
Isoniazid 300-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 232
|
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program
Griffiths Tricia, Connors Anne
|
Mar/Apr 2013
Pg. 130-134
|
Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 147
|
Meropenem 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 150
|
Stability of Rifampin in SyrSpend SF
Sorenson Bridget, Whaley Paul
|
Mar/Apr 2013
Pg. 162-164
|
Colds and Cough
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 480-483
|
Calculations
Stockton Shelly J, Saluja Hardeep Singh
|
Nov/Dec 2012
Pg. 498-499
|
Metronidazole 5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 425
|
Fluconazole 2-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 421
|
Foscarnet Sodium 24-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 336
|
Tobramycin 40-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 341
|
Treatment and Prevention of Insect Bites: Mosquitoes
Williams LaVonn A, Allen Loyd V Jr
|
May/Jun 2012
Pg. 210-218
|
Calculations
Stockton Shelly J, Saluja Hardeep Singh
|
Mar/Apr 2012
Pg. 152
|
Stability of Vancomycin in SyrSpend SF
Whaley Paul A, Voudrie Mark A II
|
Mar/Apr 2012
Pg. 167-169
|
Compounding for Treatment of Equine Infectious Diseases: An Overview
Bramwell Bethany L
|
Nov/Dec 2011
Pg. 450-457
|
Diaper Rash Relief: Common Sense Remedies and Treatments
Wiliams Kacee D, Williams LaVonn
|
Nov/Dec 2011
Pg. 464-469
|
Cefepime 1% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 500
|
Lavender Oil 4% in Polyethylene Glycol Ointment
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 503
|
Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 507
|
Vancomycin 31-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 508
|
Vancomycin 2% in Silver Sulfadiazine Cream
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 509
|
Magic Mouthwashes: A Literature Review and Discussion of Common Compositions
McElhiney Linda F
|
Sep/Oct 2011
Pg. 376-380
|
Sulfadiazine 100-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 426
|
Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions
Roy Julie, Brault Julie, Joran Pierre, Metrop Raphael, Hildgen Patrice
|
Sep/Oct 2011
Pg. 428-434
|
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate
Hergert Lisandro Y, Sperandeo Norma R, Allemandi Daniel A, Mazzieri Maria R
|
Jul/Aug 2011
Pg. 344-349
|
Waterless Alcohol-based Hand Sanitizers for the Compounding Pharmacy
Mixon William, Wood Adam P, Low Jennifer, Homan Linda
|
Jul/Aug 2011
Pg. 278-284
|
Stability of Ertapenem in an Elastomeric Infusion Device
Phipps Stephen D, Peacock Gina F, Smith Douglas L
|
May/Jun 2011
Pg. 252-254
|
Case Report: The Use of Compounded Metronidazole to Treat Clostridial and Campylobacterial Enteritis in an English Bulldog Puppy
Fellman Claire, Ray Jody, Jordan Dinah G, Hreish Viola
|
May/Jun 2011
Pg. 214-217
|
Triclosan 2% Topical Cream
Allen Loyd V Jr
|
May/Jun 2011
Pg. 250
|
Case Report: Clindamycin Hydrochloride 1% Otic Suspension in the Management of Otitis Externa in a Canine
Rudner Shara, Pora Amanda, DeMeo Jennifer
|
Mar/Apr 2011
Pg. 114-116
|
Levamisole 25-mg/mL Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 161
|
Mandl's Paint
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 162
|
Mandelic Acid 5% Cream
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 67
|
Terbenafine Hydrochloride Bilayer Nail Lacquer
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 72
|
Vancomycin Hydrochloride 25-mg/mL Solution
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 73
|
Gramicidin 13% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 519
|
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 421
|
Triclosan 0.28% Mouthwash
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 425
|
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device
Tsiouris Maria, Ulmer Marisa, Yurcho James F, Hooper Kevin L, Gui Min
|
Sep/Oct 2010
Pg. 436-439
|
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together
McElhiney Linda F
|
Jul/Aug 2010
Pg. 270-274
|
Acyclovir with Benzocaine Lip Balm
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 332
|
Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 333
|
Ampicillin 250-mg Suppository
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 335
|
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping
Tong Henry H Y, Chan Hokman, Du Zhen, Zheng Ying
|
Jul/Aug 2010
Pg. 342-345
|
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin
Baker Daniel S, Waldrop Bruce, Arnold John
|
Jul/Aug 2010
Pg. 346-349
|
Bacitracin 10,000-Units/mL Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2010
Pg. 240
|
Rifaximin 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 247
|
Voriconazole 40-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
|
May/Jun 2010
Pg. 249
|
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration
de Villiers Melgardt M, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
|
May/Jun 2010
Pg. 250-256
|
Acyclovir 5% in Oral Adhesive Paste
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 150
|
Acyclovir 200-mg/5-mL Oral Suspension (From the Injection)
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 151
|
Clotrimazole 1% Oral Adhesive Paste
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 153
|
Metronidazole in Normal Saline Enema
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 69
|
Prophylaxis Against Exposure to Bloodborne Pathogens During Compounding
Williams Angie, Mixon William
|
Jan/Feb 2010
Pg. 14-18
|
Hand Sanitizer Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 66
|
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 74
|
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Voudrie Mark A II, Allen D Brett
|
Jan/Feb 2010
Pg. 82-85
|
Cidofovir 0.2-mg/mL Intravitreous Injection
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 554
|
Fluconazole 2% Topical Microemulsion
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 555
|
Gentian Violet Vaginal Suppositories
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 556
|
Miconazole 1% Ophthalmic Solution, Veterinary
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 559
|
Voriconazole 2% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 562
|
A Review of Stomatitis and Treatment in Cats
Ray Jody D, Jordan Dinah G, Eubanks Diana L, Crosswhite Megan E
|
Sep/Oct 2009
Pg. 372-381
|
Azithromycin in the Treatment of Pneumonic Foals
Bramwell Bethany L, Williams LaVonn A
|
Sep/Oct 2009
Pg. 382-384
|
Moxifloxacin 20-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 337
|
Mupirocin 1% (20-mg) Vaginal Suppository
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 338
|
Riley Butt Cream
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 339
|
Clindamycin 100-mg Vaginal Suppositories
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 334
|
Stability of Low-Concentration Ceftazidime in 0.9% Sodium Chloride Injection and Balanced Salt Solutions in Plastic Syringes Under Various Storage Conditions
Xu Meng, Warren Flynn W, Bartlett Michael G
|
Mar/Apr 2009
Pg. 166-169
|
Treating Methicillin-Resistant Staphylococcus Aureus Infections with Compounded Vancomycin Preparations
McElhiney Linda F
|
Mar/Apr 2009
Pg. 120-124
|
Chloroquine Phosphate 64.5-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 154
|
Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 157
|
Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 64
|
Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 65
|
Dextromethorphan Hydrobromide 30-mg Troches
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 67
|
Diaper Rash Cream with Miconazole
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 68
|
Diphenhydramine Hydrochloride 25-mg Gelatin Troches
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 69
|
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution
McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H
|
Sep/Oct 2008
Pg. 456-459
|
Dichlorobenzyl Alcohol Tooth Gel
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 449
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 450
|
Compounding Challenges for Immunocompromised Patients
McElhiney Linda F
|
Nov/Dec 2008
Pg. 482-487
|
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
|
Nov/Dec 2008
Pg. 558-564
|
Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 355
|
Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm
Allen Loyd V Jr
|
May/Jun 2008
Pg. 265
|
Tolnaftate 1% Antifungal Microemulsion
Allen Loyd V Jr
|
May/Jun 2008
Pg. 268
|
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2008
Pg. 276-278
|
Acyclovir 5% Topical Ointment
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 146
|
Aminacrine Hydrochloride 0.1% Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 148
|
Chlorhexidine Gel
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 151
|
Erythromycin 1% and Neomycin Sulfate Ointment
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 153
|
Hydrogen Peroxide 8% Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 155
|
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
|
Mar/Apr 2008
Pg. 170-173
|
Emetine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 68
|
Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 73
|
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Nov/Dec 2007
Pg. 520-524
|
Chlorhexidine 2% Gel
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 507
|
Coal Tar 2% and Allantoin 2.5% Cream
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 508
|
Foscarnet 2.5% Topical Cream
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 509
|
Interferon alfa-2b Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 510
|
Miconazole 2% Oral Gel
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 512
|
Rabbit Medicine
Jordan Dinah G
|
Sep/Oct 2007
Pg. 364-374
|
The Whales: A Pharmacist's Story
Wills William R
|
Sep/Oct 2007
Pg. 376-383
|
Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 416
|
Betamethasone Valerate 0.1% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 419
|
Neomycin 0.05% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 424
|
Isoniazid Release from Suppositories Compounded with Selected Bases
Hudson Kristofer C, Asbill C Scott, Webster Andrew A
|
Sep/Oct 2007
Pg. 433-437
|
Ketoconazole 25-mg Liquid Suppository
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 329
|
Moxifloxacin in Dianeal 1.36% Peritoneal Dialysis Solution
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 331
|
Oseltamivir 12-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 332
|
Ribavirin 40-mg/mL Suspension
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 334
|
Trovafloxacin Mesylate 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 251
|
Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster
Fields Shannon W
|
Mar/Apr 2007
Pg. 131
|
Cefuroxime Axetil 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2007
Pg. 156
|
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations
Ford Stephen M, Kloesel Lawson G, Grabenstein John D
|
Mar/Apr 2007
Pg. 164-176
|
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle
Benischek Rita L
|
Nov/Dec 2006
Pg. 428-433
|
Ronidazole in the Treatment of Trichomonad Infections in Cats
Davidson Gigi S
|
Nov/Dec 2006
Pg. 434-435
|
Valacyclovir 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 461
|
Compounding for Feline Herpetic Keratitis
Davidson Gigi S
|
Nov/Dec 2006
Pg. 411-414
|
Topical Cidofovir for Treatment of Resistant Viral Infections
McElhiney Linda F
|
Sep/Oct 2006
Pg. 324-328
|
Fluconazole 1-mg/mL Liquid for Nasogastric Tube Administration
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 383
|
Dapsone 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 300
|
Itraconazole 40-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 301
|
Rifabutin 20-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 305
|
Pyrimethamine 2-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 226
|
Triamcinolone Acetonide 0.1% Mouthwash Solution
Allen Loyd V Jr
|
May/Jun 2006
Pg. 229
|
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration
Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2006
Pg. 230-233
|
Chloroquine Phosphate 15-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 138
|
Norfloxacin 20-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 142
|
Saquinavir 60-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 143
|
Terbinafine Hydrochloride 25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 145
|
Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives
Vail Jane
|
Mar/Apr 2006
Pg. 107-111
|
Efavirenz 20-mg/mL Oral Liquid, Anhydrous
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 62
|
Wiping Out Diaper Rash
Fields Shannon W
|
Nov/Dec 2005
Pg. 433-434
View Sample |
Ganciclovir 100-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 476
|
Pyrazinamide 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 478
|
Valganciclovir Hydrochloride 60-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 481
|
Metronidazole 1% and Silver Sulfadiazine 1% Cream, Veterinary
Allen Loyd V Jr
|
May/Jun 2005
Pg. 230
|
Return to Top |